Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. OpGen, Inc.
  6. News
  7. Summary
    OPGN   US68373L3078

OPGEN, INC.

(OPGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OPGEN INC : Change in Directors or Principal Officers (form 8-K)

07/29/2021 | 04:49pm EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 28, 2021, Timothy C. Dec notified OpGen, Inc. (the "Company") of his intent to resign as Chief Financial Officer (including principal financial officer and principal accounting officer) and Corporate Secretary of the Company effective as of August 20, 2021 to pursue other career opportunities. Mr. Dec will continue to serve as Chief Financial Officer (including principal financial officer and principal accounting officer) and Corporate Secretary of the Company until his resignation becomes effective, which includes the Company's filing of its Quarterly Report on Form 10-Q for the second quarter of 2021. Mr. Dec's resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, or procedures. The Company will commence a search process for Mr. Dec's replacement.

© Edgar Online, source Glimpses

All news about OPGEN, INC.
09/15OPGEN : Announces Data from Prospective Randomized Controlled Multicenter Clinical Study U..
AQ
09/15OpGen, Inc Announces Clinical Data from Investigator-Initiated and Driven Prospective R..
CI
08/13OPGEN : Note 2 - Going Concern and Management's Plans
AQ
08/13OPGEN : Corporate Presentation (PDF)
PU
08/12OPGEN : Reports Second Quarter 2021 Financial Results and Provides Business Update (Form 8..
PU
08/12OPGEN INC : Results of Operations and Financial Condition, Financial Statements and Exhibi..
AQ
08/12Opgen, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/12OPGEN : Earnings Flash (OPGN) OPGEN Posts Q2 Revenue $811,615
MT
08/12OPGEN : Reports Second Quarter 2021 Financial Results and Provides Business Update
AQ
08/05OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
More news
Analyst Recommendations on OPGEN, INC.
More recommendations
Financials (USD)
Sales 2021 3,30 M - -
Net income 2021 -38,5 M - -
Net Debt 2021 7,16 M - -
P/E ratio 2021 -2,86x
Yield 2021 -
Capitalization 117 M 117 M -
EV / Sales 2021 37,5x
EV / Sales 2022 11,5x
Nbr of Employees 102
Free-Float 99,7%
Chart OPGEN, INC.
Duration : Period :
OpGen, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPGEN, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 3,05 $
Average target price 5,00 $
Spread / Average Target 63,9%
EPS Revisions
Managers and Directors
Oliver Schacht Chief Executive Officer & Director
William E. Rhodes Non-Executive Chairman
Vadim Sapiro Chief Information Officer
Faranak Atrzadeh Chief Marketing & Scientific Affairs Officer
Johannes Bacher Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
OPGEN, INC.49.51%117
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.46.01%50 128
CELLTRION, INC.-23.54%31 745
SEAGEN INC.-7.88%29 353